Healthcare Triangle is trading at $0.50, 10.61% down in pre-market on October 8, 2026, as it faces an October 8 deadline to appeal Nasdaq’s delisting determination after failing the $1 minimum bid-price rule. - Without an appeal, trading could be suspended October 12; the company intends to request a hearing. - Shares fell from $0.72 on October 2 to $0.56 on October 7. - No separate October 8 announcement was identified; the Nasdaq notice is the clearest company-specific catalyst.